AII TV - Seminar serie - Marcel vd Brink and Nicolien de Clercq

Prof. dr. Marcel van den Brink,, MD, PhD, is Head of the Division of Hematologic Malignancies and an Attending Physician of the Adult Bone Marrow Transplantation Service at the Memorial Sloan Kettering Cancer Center in New York. As a physician-scientist he is seeing patients undergoing a bone marrow transplantation.
Dr. Nicolien de Clercq, MD, PhD, is Fellow Medical Oncology at the Amsterdam University Medical Center and is also specializing in Pain Medicine at the Department of Anesthesiology of the AUMC. Her research focusses on the role of the gut microbiota in (gastro-intestinal) cancer, wherefore she performed fecal microbiota intervention studies, under supervision of Prof. Dr. Max Nieuwdorp (Internal Medicine) and Prof. Dr. Hanneke van Laarhoven (Medical Oncology). The ultimate goal is the development of personalized treatment modalities, such as subject-specific microbiome-based prebiotics and probiotics to improve clinical outcomes in cancer patients.
His research focusses on novel strategies to improve immune therapies for cancer patients with a special emphasis on the role of the intestinal microbiome in (patho)physiology and therapy, Chimeric Antigen Receptor T cell therapy, and regeneration of thymic function to improve T cell immunity.